Search results
Can Dupilumab Halt Atopic March in Pediatric AD?
Medscape· 14 minutes agoDupilumab therapy was more effective than conventional treatments in reducing the risk of developing allergic rhinitis or asthma in children with atopic ...
Researchers tie Lebrikizumab to sustained atopic dermatitis treatment effect
Medical Xpress· 12 hours agoLebrikizumab is associated with sustained effects for moderate-to-severe atopic dermatitis for up to...
Leo’s single-dose autoinjector secures FDA approval for atopic dermatitis
Pharmaceutical Technology via Yahoo Finance· 6 days agoLeo Pharma has announced that its injection treatment for atopic dermatitis, Adbry...
Tapinarof may mark Dermavant’s first atopic dermatitis approval
Clinical Trials Arena via Yahoo Finance· 7 days agoTapinarof is an aryl hydrocarbon receptor (AhR) receptor modulator...
Union Therapeutics shares positive data on atopic dermatitis drug trial
Clinical Trials Arena via Yahoo Finance· 6 days agoDenmark-based pharmaceutical company Union Therapeutics has shared data from its ADESOS Phase 2b...
Regeneron (REGN) Outperforms Industry YTD: What Lies Ahead?
Zacks via Yahoo Finance· 12 hours agoSolid sales of Dupixent (approved for use in certain patients with atopic dermatitis, asthma,...
The Best Eczema Shampoos for an Inflamed or Itchy Scalp
US Weekly· 5 days agoIf you have seborrheic dermatitis, you may need a shampoo that has a few strong ingredients that can eliminate yeast. “Make sure you are using a shampoo with active ingredients ...
Uses and Benefits of Colloidal Oatmeal
Health via Yahoo News· 6 days agodermatitis, a type of eczema that causes scaly patches of red, purple, or gray skin. Allergies, irritants, or stress can trigger atopic dermatitis ...
Enveda Biosciences secures $55m to advance drug discovery
Pharmaceutical Technology via Yahoo Finance· 2 days agoThe lead programme of the company is an oral anti-inflammatory agent being developed to target ...
Nektar unveils promising preclinical data on NKTR-0165 By Investing.com
Investing.com· 6 days agoNektar Therapeutics (NASDAQ:NKTR) has revealed new preclinical findings on its investigative...
